Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss
Bone Res. 2022 Nov 15;10(1):64.
doi: 10.1038/s41413-022-00238-5.
1 Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
2 Department of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
3 Institute of Immunology, University of Science and Technology of China, Hefei, China.
4 Department of Orthopaedics, The First Affiliated Hospital of USTC, Hefei, China.
5 Department of Orthopaedics, Fuyang Hospital of Anhui Medical University, Fuyang, China.
6 Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. zhenghong@ahmu.edu.cn.
7 Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. sywang@ahmu.edu.cn.
8 Department of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. fangni@ustc.edu.cn.
9 Institute of Immunology, University of Science and Technology of China, Hefei, China. fangni@ustc.edu.cn.